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Abstract 
We are in the midst of a digital revolution in healthcare, although the application of new and 
useful technology in routine clinical practice is variable.  The CATCH ME Consortium, in 
collaboration with the European Society of Cardiology (ESC), has funded the creation of two 
applications (apps) in atrial fibrillation (AF) for use in smartphones and tablets.  The patient 
app aims to enhance patient education, improve communication between patients and health 
care professionals, and encourage active patient involvement in the management of their 
condition.  The healthcare professional app is designed as an interactive management tool 
incorporating the new ESC Practice Guidelines on AF and supported by the European Heart 
Rhythm Association (EHRA), with the aim of improving best-practice approaches for the care 
of patients with AF. 
Both standalone apps are now freely available for Android and iOS devices though the Google 
Play, Amazon and Apple stores.  In this paper, we outline the rationale for the design and 
implementation of these apps.  Our objective is to demonstrate the value of integrating novel 
digital technology into clinical practice, with the potential for patient engagement, optimisation 
of pharmacological and interventional therapy in AF, and ultimately to improve patient 
outcomes. 
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Condensed abstract (48 words) 
Smartphone and tablet apps are an exciting and evolving way to reach large audiences with 
healthcare education and recommended treatment pathways.  The ESC, CATCH ME 
Consortium and EHRA have designed apps for both patients with atrial fibrillation and their 
healthcare providers, available freely on Android and iOS platforms. 
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What’s New? (84 words) 
1. The 2016 ESC Guidelines on atrial fibrillation (AF) recommend patient-centred care and an 
integrated, multidisciplinary treatment approach. 
2. Smartphone and tablet apps can provide education, encourage behaviour change and 
increase treatment adherence in patients, as well as deliver interactive treatment algorithms 
to aid clinicians. 
3. The patient app aims to enhance patient education on AF, self-management and shared 
decision-making. 
4. The healthcare professional app is designed around the 2016 ESC Guidelines on AF to 
simplify the choice of treatment and optimise guideline adherence. 
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Introduction 
Smartphones, tablet computers and their applications (apps) have become ubiquitous in 
modern life all across the world.  In Europe and North America, approximately two-thirds of 
the population own mobile devices, with year-on-year increases.  Their role in our lives has 
continually changed and for many people, smartphones and tablets are the primary method for 
communication and accessing online information.  Although lagging behind social networking, 
the popularity of interactive health communication applications is growing, not only to provide 
health information, but also to combine education with the goal of behaviour change.1  Better 
patient understanding has the potential to improve health outcomes2, and in patients with heart 
disease, education allows better appreciation of individual risk and facilitates commencement 
of and compliance with treatment.3  The use of computer or web-based patient tools appears to 
have positive effects across a range of outcomes, including patient knowledge, behaviour, and 
even clinical outcomes (for example improved diabetic control or less disability from asthma).4  
On the other side of the consultation, there are many medical apps available to assist doctors, 
although few, to-date, have been specifically written by and for clinicians.5 
 
Atrial fibrillation (AF) is the most common heart rhythm disorder and poses a considerable 
burden to healthcare services, with rising incidence and prevalence, and high rates of morbidity 
and mortality.6  Aside from the prognostic benefit of oral anticoagulation therapy and 
management of cardiovascular risk, treatment of AF is targeted towards the relief of symptoms, 
including the control of heart rate and rhythm.7  Adherence to long-term therapy is of particular 
importance, supported by a multidisciplinary team that includes primary care practitioners, 
cardiologists, electrophysiologists, stroke physicians, allied health professionals and support 
staff.  Management of AF is therefore uniquely suited to a process of shared decision making8, 
to support the patients’ understanding of the disease and available therapies.9  Patient education 
can improve anticoagulation control in AF patients10 , and integrated AF management is a cost-
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effective means of reducing unnecessary hospital admissions and adverse clinical outcomes.11, 
12  From the perspective of healthcare professionals, adherence to clinical practice guidelines 
have been shown to improve prognosis in patients with AF.13-15   
 
In concert with the 2016 European Society of Cardiology (ESC) Guidelines on AF7, we are 
launching mobile applications for patients with AF and their healthcare professionals (Figure 
1).  The patient app aims to enhance patient education, optimise communication between 
patients and healthcare providers, increase patient involvement in management decisions, and 
encourage self-management activities.  The healthcare professional app is designed to 
interactively apply the new ESC AF Guidelines to individual patients, facilitating the adoption 
of best-practice management of AF, with the aim of improving patient outcomes. 
 
   
Rationale 
The patient and healthcare professional apps for AF were developed to disseminate the new 
2016 ESC AF Guidelines through different formats, in order to reach a wide and expanding 
audience.  Our approach had three main foundations that are discussed in detail below:   
(1) Apps in other healthcare settings have had a positive impact on patient behaviour and 
clinical outcomes; (2) Digital learning in the context of educational theory affords a new 
pathway of providing supportive patient education; and (3) Education of healthcare 
professionals and encouraging guideline-adherent care can contribute to enhanced professional 
standards and improved management of patients with AF. 
   
(1) Evidence from other healthcare apps 
The impact of health-related apps have been studied in numerous randomised controlled trials.  
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During our design phase, we performed a keyword search of PubMed and Google Scholar to 
identify apps with published health outcomes (April 2016; search terms apps/mobile and 
randomised), and summarise some key trials here.   An app providing cognitive behavioural 
therapy skills demonstrated reduced symptoms of depression and less work absence compared 
to those randomised to website support (n=300).16  In 597 adults with back pain, a mobile app 
successfully encouraged self-management skills, leading to a reduction in back pain at 4 
months.17  A web-based app on healthy lifestyle interventions had a positive impact on 
physical activity over 14 weeks in 56 participants compared to 29 controls (63 ± 21 minutes 
versus -30 ± 28 minutes; p=0.02), leading to more weight loss and higher success in 
maintaining a healthy lifestyle.  The frequency of app use was significantly related to a higher 
success score.18  Short-term benefits over an 8-week period were also seen with an app that 
encouraged physical activity using social networking (n=110).19  In patients at risk of diabetes, 
a combined mobile app and pedometer increased physical activity, reduced blood pressure, and 
improved dietary intake in 30 patients compared to 31 controls.20  However, in another 
randomised trial, a mobile phone app was unable to elicit any improvement in physical activity 
at 8 weeks (n=51).21  An app designed to improve adherence to medications in elderly patients 
led to fewer missed doses compared to controls (n=48 and 51 respectively), and 88% of those 
using the app felt more independent in managing their therapy.22  
The studies discussed above have important limitations, including highly motivated and 
selected populations, and only short-term evaluation.  A systematic review of mobile health 
interventions suggests a benefit from various types of intervention, but also a clear need for 
further robust evidence.23   
 
(2) Context of educational theory 
Learning theories have progressed from purely behaviourist (passive learning in response to 
external stimuli; e.g. Pavlov’s conditioning), through cognitivist learning (internalisation of 
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knowledge), and more recently constructivist models (learning through the experience of 
knowledge).24, 25  These theories have formed the basis for optimal teaching methods during 
the last century26, however the availability of new technology has the potential to embed 
digital-aided learning within routine clinical practice.27  Although access to information and 
technology systems has increased exponentially, the corresponding levels of use within 
education remains modest.28  There are also important limitations that can impede digital 
learning, such as language, culture and baseline knowledge, as well as app functionality and 
readability.29-31   
So what are the theoretical implications for app development to assist patients with AF?  
Figure 2 adapts Salmon’s five-stage model of online learning32 to illustrate the key points of a 
structured developmental process.  These can lead to patient enablement (provision of 
appropriate context for new knowledge and skills)33, and hence, supported and successful 
learning (as described by Vygotsky’s Zone of Development).34  Reflecting on the learning 
classification described by Bloom35, users start to understand new concepts and apply 
knowledge to their own circumstances.  One of the aims of our app is to allow independent 
patient evaluation of treatment options, enabling an informed choice and partnership-in-care 
between patients and their healthcare providers.  Such a model has the potential to encourage 
satisfaction with treatment, increase self-management, reduce cost and improve patient well-
being. 
 
(3) Context of professional standards 
Physician education:  Professional standards frameworks across Europe highlight the 
importance of ongoing education.  In this context, mobile applications are an important part of 
integrating and internalising knowledge, as well as transmitting this learning to others.36-39  The 
general direction of technology suggests that mobile applications will become an increasingly 
important method to improve and maintain professional standards in healthcare.40  
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Physician interaction with patients:  The active participation of patients in healthcare 
consultations and development of patient autonomy is a principle common to professional 
standards across the world.41  This includes the Physician Charter42, adopted by the European 
Federation of Internal Medicine, the American Board of Internal Medicine and the American 
College of Physicians, as well as standards of the UK General Medical Council.39  The 
CanMEDS code of the Royal College of Physicians and Surgeons of Canada puts a 
responsibility on physicians to facilitate patient learning, not only by educating patients but 
also by promoting health literacy for the purposes of “establishing rapport and trust, 
formulating a diagnosis, delivering information, striving for mutual understanding, and 
facilitating a shared plan of care”.43  Similarly, the Core Curriculum for General Cardiologists 
of the ESC and the Core Curriculum for Nurses of the ESC Council for Cardiovascular 
Nursing and Allied Professions recognise the importance of patient education in all areas of 
cardiac care.44, 45  
 
Design 
App design was led by a core-group (see Appendix 1), comprising of representatives from the 
CATCH ME Consortium (Characterizing Atrial fibrillation by Translating its Causes into 
Health Modifiers in the Elderly), the ESC Guidelines Task Force on AF, and the European 
Heart Rhythm Association (EHRA).  Börm Bruckmeier Publishing (Germany) were 
commissioned to produce the apps.  The main components and objectives of the app 
development programme are displayed in Figure 3.   
 
In brief, we developed the apps in tandem with the writing of the 2016 ESC Guidelines on AF, 
whilst maintaining the confidentiality of the guidelines.  The Task Force writing the guidelines 
were instrumental in defining the content of the apps.  The guideline flowcharts for different 
sections of AF management determined the design of the apps.  This process begun in October 
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2014, an outline of the app functionalities was completed in October 2015, and the final 
guideline structure was incorporated into the Apps Software Requirements Specification by 
February 2016.  Model View Presenter Framework (Android) and Model View Controller 
(iOS) were used, with the overall product based on Client Server Architecture.  Both 
standalone apps are scheduled for public release at the time of this publication, with the 
interconnectivity of the two apps to follow.  As the Healthcare Professional app determines 
patient treatment, a CE certification application has been submitted to conform with European 
Commission Directives (Class IIa medical device).  
 
Patient app 
The patient app will provide education on AF, including sections describing the pathology, 
symptoms, prognosis, associated comorbidities, management strategies, and practical tips for 
self-care (Figure 4-A).  Information was derived from existing patient documentation 
developed by the British Heart Foundation (https://www.bhf.org.uk/), the German National 
Network of Competence in Atrial Fibrillation (AFNET; http://www.kompetenznetz-
vorhofflimmern.de/), and a patient booklet on AF developed in the Netherlands.46  The text 
was then edited by a team of patient representatives with AF (funded through a UK National 
Institute of Health Research grant on improving patient outcomes in AF).47  The patient app 
will also present information on individual stroke risk, and provide a personal health record 
and symptom diary.  Patients are asked to fill in sections about relevant previous health issues 
which can facilitate consultation when shared with their healthcare professional(s).   
 
Healthcare professional app 
The healthcare professional app is a more complex tool, allowing both conventional viewing of 
guideline text and recommendations, as well as interactive treatment algorithms (Figure 4-B).  
The app is also designed to improve consultation efficiency, with the provision of a patient 
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register, prefilled with data supplied by the patient.  A tablet version of the app will also be 
available, allowing overview of multiple patients (for example, in an outpatient clinic setting).  
Users are able to launch the AF Treatment Manager directly through the existing ESC Pocket 
Guidelines app, available now free of charge for iOS and Android devices through their 
respective stores.  
 
Patient to doctor communication, security and privacy 
A key feature of the apps is communication between consenting patients and their healthcare 
professional(s).  Patients will be able to securely share their data through a cloud server, 
permitting healthcare professionals to import relevant information into the healthcare 
professional app (such as symptoms, stroke risk factors, and medications).  The patient can 
disable this access at any time.   All shared information is encrypted and password protected.  
Reciprocally, the healthcare professional can also share collated information with the patient, 
in the form of an automated email. 
 
Potential for observational research 
For patients who specifically consent to the use of data for research purposes, anonymised data 
will be saved for future exploration of symptomatology, treatment patterns and guideline 
adherence.  This is an unparalleled capability, allowing us to collate information on patients 
with AF across all communities, including primary practice and hospital clinics.  
Understanding the barriers to effective guideline implementation will help to improve future 
guidelines on AF, and make them more relevant to patient care. 
 
Evaluation 
Evaluation of the apps is essential to determine their ability to provide knowledge to patients 
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and healthcare professionals, and their impact on guideline adherence.  This is an ongoing 
process, and feedback will drive the further development of these tools.   
The process of initial testing and evaluation was as follows: 
i. Appraisal by members of the ESC AF Guidelines Task Force to ensure that content for 
both patient and healthcare apps followed guideline recommendations. 
ii. In-house testing of individual components by the app development team, including at 
least fortnightly confidential teleconferencing updates during the finalisation of the 
2016 ESC AF Guidelines.   
iii. Initial evaluation was centred around interface design, technology and acceptability, 
using published scales that help evaluate healthcare smartphone applications (see 
Appendix 2).48, 49  
iv. Discussions and protocol development for patient data protection, data storage and 
security. 
v. Patient-facing materials (educational text and images) were designed and reviewed by a 
patient involvement team and representatives of the British Heart Foundation. 
vi. Testing of each app in entirety by the app development team, to identify programming 
errors and inconsistencies. 
vii. Confidential testing and design enhancement by the wider ESC AF Guidelines Task 
Force, members of the CATCH ME consortium and EHRA to improve app 
functionality.  
viii. Beta-testing using self-contained devices within user cohorts to ensure acceptable 
language, ease-of-use and clinical utility.  The apps were tested by a group of CATCH 
ME investigators and junior and senior clinicians at the CATCH ME clinical centres on 
three occasions throughout 2016.  Further testing regarding content and usability was 
carried out during the AFNET/EHRA Consensus Conference (January 2017) by AF 
clinicians and specialists. 
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ix. Updates following beta-testing and finalisation of app design.  Beta-testing was 
performed by 67 persons (iOS and Android, both patient and healthcare professional 
apps), with feedback leading to new test versions.  In total, there were 50 test versions 
of the apps, with step-wise iterations leading to better functionality. 
 
Post-publication feedback:  As surveying users can often be biased, the apps will include an 
anonymous feedback option for comment on features that work or do not work well.  Although 
web-based surveys also suffer from sampling biases, they do allow more self-disclosure50 and 
are likely to be a more useful tool for evaluation and subsequent app modification.   
 
 
Discussion 
The development of smartphone and tablet apps for patients and healthcare professionals is an 
exciting opportunity to increase active patient involvement in the management of their AF, 
provide education to patients and healthcare professionals, and potentially improve clinical 
outcomes through the pursuit of guideline-adherent care.  This approach is well-suited to 
provide structured and integrated management of AF, as recommended in the 2016 ESC AF 
Guidelines.7  
 
As discussed above, there is a good rationale behind the development of apps in AF, including 
evidence from other healthcare applications showing improvement in patient management.51  
The apps also provide a new method to support patient empowerment through education, as 
well as easily accessible ‘on-the-job’ healthcare professional training.  The ability of the apps 
to enhance learning is based on a number of educational theories that offer users not only 
knowledge from evidence-based guidelines, but also the application and reinforcement of this 
information within a digital platform.  The healthcare professional app also addresses a number 
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of key professional standards for the development of good clinical practice, in regards to 
personal continued professional development and establishing an integrated, patient-centred 
approach to care.  The long-term management of chronic conditions like AF is likely to benefit 
from informed and autonomous patients52, 53, potentially leading to better outcomes through 
shared decision making.8, 54, 55  Although patient information is now widely available through 
written and verbal information, there remains a lack of specific knowledge related to AF.56-58  
Currently available education tools are almost entirely focused on anticoagulation therapy10, 59-
61, and although of clear clinical importance, this may not match what patients want and need 
to know about AF in general.62, 63  The huge advantage of our app-based tools are the dynamic 
nature of the technology, allowing us to add and modify features or information sources in 
response to user feedback and reflecting future updates of the ESC AF guidelines.   
 
App-based interventions are a relatively new method of education in healthcare, however there 
is a large body of evidence for online learning in the teaching profession.  In a systematic 
review of 99 studies, face-to-face and online learning methods were examined in a variety of 
topics for undergraduate and postgraduate learners.  Effect sizes were largest for the 
combination of face-to-face and online instruction compared to either separately, and online 
working was more efficient if directed or collaborative, rather than  
independent student learning.64  To extrapolate to use of medical apps, this reinforces the need 
for the patient app to be part of the clinical experience, underpinned by the standard 
educational approach from healthcare professionals.  Similarly, the healthcare professional app 
should be used in the context of ongoing professional development to achieve improvements in 
clinical management.  New innovations usually go through a peak and trough of usage (the so-
called ‘hype cycle’), and the design group were therefore keen to ensure that the apps retain 
relevance and functionality over time by including the means for continual update and 
improvement.  The rapid rate of change in technology itself creates a number of issues related 
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to access, ethical process and privacy.  However, as the general public move towards greater 
acceptance (and reliance) on mobile platforms, the medical community have an opportunity to 
use these advances to improve patient care.    
 
Limitations 
There are limitations to our approach, most notably that not all patients and healthcare 
professionals will have access to smartphones or tablets.  However, recent data from the US 
suggest that even in adults over the age of 65, internet use is increasing exponentially and that 
around 70% now own a mobile phone (although smartphones in this age group are still less 
common).65  The main barriers to smartphone use in older patients appears to be related to lack 
of perceived knowledge around the technology and visual impairment.66  Both of these issues 
were considered during the design phase of the apps, with the use of ‘patient-approved’ 
education materials, simple functionality, straightforward layout and readable font size. 
Finally, although digital forms of learning are increasing and may provide benefit67, there is a 
tendency to over-value the use of technology.68  Put simply, we should ensure that the time 
spent in learning and using a new resource is time and cost-efficient, with sustained value over 
any short-term (or gimmick) objectives.  Our aim was to achieve good productivity of both the 
patient and healthcare professional apps, and for usage to increase over time, whilst accepting 
that our initial designs are likely to need ongoing improvements in response to the changing 
requirements of patients with AF and their healthcare providers. 
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Conclusions and Clinical Perspective 
We have outlined the rationale for new smartphone and tablet applications for patients with 
atrial fibrillation and their healthcare professionals, reviewing the evidence for improving 
patient outcomes, enhancing professional standards, and supporting the use of digital learning.  
Our clinical aim is to increase patient engagement and guideline-adherence with AF 
management, and ultimately, improve patient well-being and long-term prognosis.  The apps 
are freely available for Android and iOS devices. 
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Figure legends 
Figure 1: QR scan codes - Download the apps now! 
Scan these codes to download the apps (iOS or Android). 
 
Figure 2: Learning framework applied to the AF apps 
Process and facilitation of online learning associated with smartphone applications for AF.  
Adapted from the five-stage model as proposed by Salmon (2013).32 
AF = atrial fibrillation; HCP = healthcare professional. 
 
Figure 3: Components and objectives of the app development programme 
AF = atrial fibrillation; ESC = European Society of Cardiology. 
 
Figure 4: Screenshots of the patient app (A) and the healthcare professional app (B). 
Both apps available free of charge for Android and iOS through the Google Play, Amazon and 
Apple stores.  The AF treatment manager is available now through the ESC Pocket Guidelines 
app (AF section).  All names displayed in the figure are fictitious. 
 
  







